Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?

In recent years, advances in pharmaceutical processing technologies have resulted in development of medicines that provide therapeutic pharmacokinetic exposure for a period ranging from weeks to months following a single parenteral administration. Benefits for adherence, dose and patient satisfactio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatham, Lee M., Liptrott, Neill J., Rannard, Steve P., Owen, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695729/
https://www.ncbi.nlm.nih.gov/pubmed/31344834
http://dx.doi.org/10.3390/molecules24152685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695729/
https://www.ncbi.nlm.nih.gov/pubmed/31344834
http://dx.doi.org/10.3390/molecules24152685

Ejemplares similares